Sport & Auto
- About Future
- Digital Future
- Cookies Policy
- Terms & Conditions
- Investor Relations
- Contact Future
Hyper-aggressive position for the sprint lead-out
How much air pressure pros use at the Tour de France
National theme bike for Tour's lone Japanese rider
Teams bringing multiple models of sponsor bikes
Chris Froome (Tea Sky) wins the points classification
No rules broken in fast tracking
The World Anti-Doping Agency say that they are happy that the UCI have followed the rules when they issued Team Sky's Chris Froome a Therapeutic Use Exemption (TUE) for prednisolone at the Tour de Romandie.
Froome fell ill during the race and the Sky team doctor Allen Farrell put in the TUE application to allow Froome to take 40mg of the oral corticosteroid, per day. French newspaper La Journal du Dimanche reported that the UCI medical adviser Dr Michele Zorzoli had fast-tracked the TUE application at the Tour de Romandie.
“WADA is satisfied that the UCI’s decision to grant a Therapeutic Use Exemption (TUE) to Chris Froome was conducted according to the rules of the International Standard for Therapeutic Use Exemptions (ISTUE), and therefore will not be reviewing this case any further,” WADA said in a statement emailed to Cyclingnews.
“WADA monitors the applications for, and approvals of, Therapeutic Use Exemptions (TUEs) and has the ability to review TUE decisions in line with the ISTUE.”
The WADA code allows for 'exceptional circumstances’, when a rider is already competing in a major event. The UCI insist that Zorzoli, as UCI doctor and Scientific advisor, has been given permission by the UCI TUEC (Committee) to give out TUEs for exceptional circumstances.